Exposure to a deuterated analogue of phenylbutyrate retards S-phase progression in HT-29 colon cancer cells

Journal of Pharmaceutical Sciences

Volumn 91, Issue 4, 2002, Pages 1054-1064

  Clarke, Kevin O ^a   Ludeman, Susan M ^a   Springer, James B ^a   Michael Colvin, O ^a   Lea, Michael A ^b   Harrison, Lawrence E ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

Cell cycle; Colon cancer; Fatty acid; Phenylbutyrate

Indexed keywords

2,2,3,3 PHENYLBUTANOIC ACID DERIVATIVE; ARYLBUTYRIC ACID DERIVATIVE; BUTYRIC ACID; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHEMICAL MODIFICATION; COLON CANCER; CONTROLLED STUDY; DRUG EXPOSURE; DRUG HALF LIFE; DRUG POTENCY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOSIS; PHENOTYPE; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION;

EID: 0036279444     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10102     Document Type: Article

References (23)

1. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines
2. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells
3. cdc2 activity
4. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate
5. Butyrate as a differentiating agent: Pharmacokinetics, analogues and current status
6. Modifying histones to tame cancer: Clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors
7. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis
8. Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine
9. Effects of sodium butyrate on human colonic adenocarcinoma cells
10. Ethyl isocrotonate
11. The reaction of sodium borohydride with nickel acetate in ethanol solution - A highly selective nickel hydrogenation catalyst
12. Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase
13. Dietary fiber, vegetables and colon cancer: Critical review and meta analysis of the epidemiological evidence
14. Short-chain fatty acids in the human colon
15. Induction of carcinoembryonic-antigen-gene expression in human colorectal carcinoma by sodium butyrate
16. Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells
17. Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats
18. Phenylacetate inhibits isoprenoid biosynthesis and suppresses growth of human pancreatic carcinoma
19. Phenylacetate: A novel nontoxic inducer of cell differentiation
20. Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate
21. Changes in E2F binding after phenylbutyrate-induced differentiation of Caco-2 colon cancer cells
22. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
23. Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function